According to Mallinckrodt Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 0.0072.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.0072 | -86.9% |
2022-12-31 | 0.0552 | 63.36% |
2021-12-31 | 0.0338 | 102.53% |
2020-12-31 | 0.0167 | -88.97% |
2019-12-31 | 0.1512 | -66.83% |
2018-12-31 | 0.4560 | 52.68% |
2017-12-31 | 0.2986 | -71.45% |
2016-12-31 | 1.05 | -35.33% |
2015-12-31 | 1.62 | -28.72% |
2014-12-31 | 2.27 | -2.08% |
2013-12-31 | 2.32 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.30 | 73,255.19% | ๐บ๐ธ USA |
General Electric GE | 5.67 | 78,338.92% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 2.29 | 31,531.84% | ๐ฎ๐ฑ Israel |